Structure, function, and molecular defects of factor IX.
about
Nonsense-mediated mRNA decay among coagulation factor genesComputationally derived points of fragility of a human cascade are consistent with current therapeutic strategiesCharacterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines.Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes.Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.An insertion within the factor IX gene: hemophilia BEl Salvador.Factor IXPortland: a nonsense mutation (CGA to TGA) resulting in hemophilia BExpression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients.The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IXA factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanismBinding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivationA factor IX-deficient mouse model for hemophilia B gene therapy.Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden.Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4.Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.
P2860
Q26747371-3039397A-7B92-4F13-929F-43CA97438FDEQ28469258-27E25A01-8992-4AF9-8E55-F48DC096D339Q34077417-3537AF42-1B97-4EF7-A219-9E6C02F179DEQ34121158-7F530CF0-B2C5-4921-BF56-E7A601BCE907Q34266659-B42F7704-CD4A-48E4-B5CD-69D3614B53B5Q34567824-3273A406-23BC-48B5-A828-999E7B816C0EQ34573791-9C82CC05-6569-433A-9E5E-B6BD6B2C3CC9Q35245868-C11BD7EB-0D35-4B0F-A01B-BABBC5FDC3A9Q35247962-EA5167A9-2B60-4EC2-A319-9D08E231CCE1Q35778746-CD71B208-3A80-4BF7-A337-68F9133E2C7CQ35982283-5FE527B8-7E28-4846-8672-3323D8777215Q35988428-3E6462EF-9FE8-4D6E-988B-B4A376C77BB1Q36558883-0FE3F62C-4284-46EF-9A21-EF0F616BF6E2Q36602472-11D4A490-01C2-4275-85C8-0375E2F50F27Q37103627-1C8D5F1A-3A5F-4B61-9597-8A18DC83A523Q40342950-C6887FC3-B1BC-4505-8F92-1DEFCC28BE43Q40391746-42CAF039-56E4-40FD-AFB7-A4AF2C860D37Q42019947-4C3A4012-3F55-439F-872C-0E066B064E4CQ42807080-141FF555-6415-4604-8B28-31E8799746CEQ49988033-0029C786-1CED-4672-900F-055750A707D6
P2860
Structure, function, and molecular defects of factor IX.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Structure, function, and molecular defects of factor IX.
@en
Structure, function, and molecular defects of factor IX.
@nl
type
label
Structure, function, and molecular defects of factor IX.
@en
Structure, function, and molecular defects of factor IX.
@nl
prefLabel
Structure, function, and molecular defects of factor IX.
@en
Structure, function, and molecular defects of factor IX.
@nl
P1433
P1476
Structure, function, and molecular defects of factor IX.
@en
P2093
Thompson AR
P304
P407
P577
1986-03-01T00:00:00Z